INTERNATIONAL PATENT: HIGHFIELD BIOPHARMACEUTICALS CORPORATION FILES APPLICATION FOR "LNP-ENCAPSULATED NUCLEIC ACID ENCODING A GLP-1 RECEPTOR AGONIST AND USES THEREOF"

GENEVA, Dec. 21 -- HIGHFIELD BIOPHARMACEUTICALS CORPORATION (2-202, Building 2, 658 BinAn Road, BinJiang DistrictHangzhou, Zhejiang 310051) filed a patent application (PCT/CN2024/100732) for "LNP-ENCAPSULATED NUCLEIC ACID ENCODING A GLP-1 RECEPTOR AGONIST AND USES THEREOF" on Jun 21, 2024. With publication no. WO/2025/255866, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): XU, Yuhong (2-202, Building 2, 658 BinAn Road, BinJiang DistrictHangzhou, Zhejiang 310051), XU, Fengwei (2-202, Building 2, 658 BinAn Road, BinJiang Di...